Handelsbanken Fonder Ab Twist Bioscience Corp Transaction History

Handelsbanken Fonder Ab

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	BUY	$26.2 - $54.0 $34,060 - $70,200	1,300 Added 21.67%	7,300 $255,000
Q1 2022 May 11, 2022	SELL	$38.58 - $83.27 $111,882 - $241,483	-2,900 Reduced 32.58%	6,000 $296,000
Q4 2021 Feb 08, 2022	SELL	$75.47 - $135.88 $2.66 Million - $4.78 Million	-35,200 Reduced 79.82%	8,900 $689,000
Q2 2021 Aug 03, 2021	BUY	$88.13 - $142.06 $3.24 Million - $5.23 Million	36,800 Added 504.11%	44,100 $5.88 Million
Q1 2021 Apr 29, 2021	BUY	$105.48 - $207.97 $31,644 - $62,391	300 Added 4.29%	7,300 $904,000
Q4 2020 Feb 11, 2021	BUY	$76.64 - $167.89 $130,288 - $285,413	1,700 Added 32.08%	7,000 $989,000
Q3 2020 Nov 13, 2020	BUY	$45.46 - $78.79 $240,938 - $417,587	5,300 New	5,300 $403,000

258

66.6M

127K

45.4K

Ticker TWST
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 56,363,500
Market Cap $2.57B
Description
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

Stay updated on Handelsbanken Fonder Ab with notifications on news.